Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOPE-70: Low vs Moderate Intensity Rosuvastatin in Elderly
NCT03770312Phase 4Recruiting
- Sponsor
- Yonsei University
- Start
- Mar 2020
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rosuvastatin in hypercholesterolemia and cardiovascular disease (CVD), sponsored by Yonsei University. Started Mar 2020; status: recruiting.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemiacardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03770312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770312.